Light as an Aid for Recovery in Psychiatric Inpatients

May 2, 2018 updated by: University of Aarhus

Light as an Aid for Recovery in Psychiatric Inpatients: A Pragmatic Randomized Controlled Pilot Trial

The purpose of this pilot study is to evaluate wether a naturalistic indoor light environment can improve sleep and mood in psychiatric inpatients

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Setting: 17 bed inpatient ward at a University Mental Health Hospital

Rooms: The dimensions of all 17 rooms are identical with 4,54m x 3,14m, ceiling height 3,15m, a window, a bed, a table, a chair and a bathroom 1,55m x 1,85m.

Assignment of interventions: After admission patients are invited to participate in the study. If the patients wish to participate they will go through eligibility screen, sign informed consent and fill out questionnaires on sleep, mood and well-being (-t1). The patients (now participants) are randomly allocated (t0) by sealed envelope technique and the envelope is brought to the staff office and opened by a staff member who then from the computer in the office programs the participant's room to either intervention or control.

Randomization: The investigators used random permuted blocks of varying and blinded block size. A third party person created the envelopes and arranged them in blocks.

Blinding: The outcome assessor and data analyst is blinded to allocation. Trial participants and care providers are unblinded. Participants may be replaced to another room for practical, clinical reasons. In this case, the intervention/control conditions will follow the patient.

Data management: All data will be entered in RedCAP and stored in a electronic online secured database at Aarhus University.

Power estimation: Alfa: 0.05. Beta: 0.20. Effect size: change of 4 points in PSQI with a standard deviation estimated to 4. Number of patients in each arm: 17 (x 2 = 34). Number needed to be included accounting for discontinuation: 60 (estimated)

Statistics: The investigators will calculate intention-to-treat. Other statistical analyses will include logistic regression for dichotomous outcome data, analysis of covariance for continuous outcome data, and survival analysis for time-to-event outcome data. Interim-analyses during the data-collection period to stop trial if intervention produces larger than expected benefits or harm or if investigators find evidence of no important difference between experimental and control interventions.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jylland
      • Risskov, Jylland, Denmark, 8240
        • Department of Affective Disorders, Aarhus University Hospital, Risskov

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 68 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Admission

Exclusion Criteria:

  • Inability to provide written consent
  • Mania

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dynamic lighting
Indoor lighting with low-lux no-blue wavelengths at night.

Intervention is rooms with light settings imitating natural light conditions with white light at day and low-lux no-blue light at night:

07am-10am: white light, increasing intensity 10am-07pm: white light, full intensity 07pm-11pm: no blue wavelength, low intensity 11pm-07am: no blue wavelength, very low intensity

Other Names:
  • Illumination, lighting design, lighting environment
No Intervention: Treatment as usual
Characterized by full white light with little variation through a day cyclus.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Sleep quality on the Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depressive symptoms on the Major depression inventory (MDI)
Time Frame: Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
Well-being on the World Health Organization measure of well-being (WHO-5)
Time Frame: Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
Qualitative assessment using a custom made questionnaire
Time Frame: Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
Number of patients with side-effects.
Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
Sleep diary
Time Frame: Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to discharge
Time Frame: Assessed through study completion, an average of 1 month, up to 6 months
Number of days between admission and discharge
Assessed through study completion, an average of 1 month, up to 6 months
Involuntary restraints
Time Frame: Assessed through study completion, an average of 1 month, up to 6 months
Number of participants who experienced involuntary physical and/or medical restraints.
Assessed through study completion, an average of 1 month, up to 6 months
Use of medication from logged activity in the electronic medical record
Time Frame: Assessed through study completion, an average of 1 month, up to 6 months
Use of medication during admission including drug og dosages administered to the participants in mg/day.
Assessed through study completion, an average of 1 month, up to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Niels Okkels, MD, Aarhus University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2015

Primary Completion (Actual)

January 15, 2017

Study Completion (Actual)

March 15, 2018

Study Registration Dates

First Submitted

December 4, 2015

First Submitted That Met QC Criteria

January 11, 2016

First Posted (Estimate)

January 12, 2016

Study Record Updates

Last Update Posted (Actual)

May 3, 2018

Last Update Submitted That Met QC Criteria

May 2, 2018

Last Verified

October 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • QLIGHT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Illness

Clinical Trials on Dynamic lighting

Subscribe